Cyprotex

New blog! Discover how AI, machine learning, and in vitro assays are revolutionizing cardiotoxicity risk assessment in drug discovery. Explore our latest advancements in predicting cardiac risks, improving drug safety, and accelerating the development process. Check out the full blog here: https://hubs.ly/Q02SjSzR0 #AI #MachineLearning #DrugDiscovery #Cardiotoxicity

Join us for our upcoming webinar, Drugging the Gut Microflora to Reduce Drug Toxicity, hosted by Technology Networks, where we will explore how gut bacteria influence drug metabolism and potential toxicity. Date: 6th November 2024 Time: 4pm GMT | 5pm CET | 11am EST | 8am PST Host: Technology Networks Registration link:https://hubs.ly/Q02VHHms0 #researchneverstops #cyprotex #webinar

Evotec SE announced progress within the company’s strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline. Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology, triggering a program-based payment of US$ 50 m to Evotec. Based on potential program-based milestones, the expansion contributes to the deal value. Read the full press release to learn more- https://hubs.ly/Q02Vq--N0 #TogetherForMedicinesThatMatter #MolecularGlueDegraders #Proteomics

Meet our expert, Joanne Wilcock, from the Drug Metabolism team at Cyprotex and learn more about our services here: https://hubs.ly/Q02TNnVK0 Contact us to learn more about our ADME services at: enquiries@cyprotex.com. #researchneverstops #cyprotex #ADME

At the upcoming SLAS Sample Management Symposium, hosted at Evotec's Campus Curie site in Toulouse, the Evotec and Cyprotex teams are presenting multiple posters which showcase our commitment to advancing sample management through innovative technologies and optimized processes. Our poster titles and authors include: 16 October session: • Isabelle Bergere: BraMosA: Our New Smartcel-2 boosting Serial Dilution Preparation • Kevin Joseph Cross: Cyprotex Sample Management – Supporting Our Future • Suzana Khoder: Transferring Evotec’s Screening Library to AcoustiX Tubes: State-of-the-Art Technology at the Service of Increased Efficiency and Reduced Compound Consumption • Delphine Merat: Up-to-date technology and optimized organization for Sample Management 17 October poster session: • Isabelle Bergere: Leveraging Sample Management Strengths to Support Biologics Research • Isabelle Bergere: No compromise! Combining Quality, Flexibility and Reliability with the new JFM integration for the CyBio well Vario • Emiliano Cuadrado Rodriguez: Evotec’s Basic Performance Verification processes for DMSO based liquid handlers • Fabrice Turlais: Setting up biological storage capabilities in Sample Management, Evotec Toulouse For more info, and to schedule a meeting with us, visit here: https://hubs.ly/Q02T6Lpf0 We look forward to seeing you in Toulouse and to discussing our science with you. #SLAS2024 #SampleManagement #DrugDiscovery

Check out our latest Cyprotex newsletter! Register for our upcoming webinar, read about our advanced #ADME-Tox services, high throughput screening, and new developments in diverse modality testing. Plus, don’t miss our exclusive discount on Phys Chem profiling available until the end of 2024! Read more here: https://hubs.ly/Q02T29N80 #Biotech #Pharma

New blog! Discover how AI, machine learning, and in vitro assays are revolutionizing cardiotoxicity risk assessment in drug discovery. Explore our latest advancements in predicting cardiac risks, improving drug safety, and accelerating the development process. Check out the full blog here: https://hubs.ly/Q02SjWpg0 #AI #MachineLearning #DrugDiscovery #Cardiotoxicity

Join us for our upcoming webinar, Drugging the Gut Microflora to Reduce Drug Toxicity, hosted by Technology Networks, where we will explore how gut bacteria influence drug metabolism and the potential for toxic compound release. Our expert speaker, Anna Kerins, will discuss the critical role of gut bacterial β-glucuronidase (GUS) and how inhibiting GUS enzymes can reduce gut toxicity, improve patient outcomes, and enable higher drug doses. The session will highlight in vitro and in vivo studies of two GUS inhibitors, demonstrating their efficacy in preventing gut damage across species. #researchneverstops #cyprotex #webinar

Come find us at ELRIG Drug Discovery at booth number 20 and meet our expert Alexander Kelly! We're also really excited to share that our Evotec colleague Sven Schreiter, will be presenting tomorrow within the Robotics, Automation, Data and AI track. Presentation title: Automated High Content Screening – Cell Painting to Accelerate Drug Discovery through Data Date and Time: Tuesday, 3rd October; 12:15 – 12:30 If you can't make it to ELRIG but would like to talk to Sven, the Evotec or Cyprotex team, you can always reach us on enquiries@cyprotex.com #ELRIG #drugdiscovery

The permeability of drugs is an important factor in oral absorption. Cyprotex offers a number of different models to study permeability including Caco-2 cells, MDCK-MDR1 cells and PAMPA as well as a panel of transporter assays for your early ADME screening studies. Download our service sheet to learn more: https://hubs.ly/Q02Rw_wL0 Reach out to us to discuss your project: enquiries@cyprotex.com #researchneverstops #cyprotex #adme